Found: 25
Select item for more details and to access through your institution.
Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 77, doi. 10.1007/s00280-014-2479-8
- By:
- Publication type:
- Article
Absorption, distribution, metabolism, and excretion (ADME) of C-sonidegib (LDE225) in healthy volunteers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 63, doi. 10.1007/s00280-014-2468-y
- By:
- Publication type:
- Article
Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers.
- Published in:
- 2014
- By:
- Publication type:
- journal article
High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with (99m)Tc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor Fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 95, doi. 10.1007/s00280-014-2471-3
- By:
- Publication type:
- Article
A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 117, doi. 10.1007/s00280-014-2474-0
- By:
- Publication type:
- Article
Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 151, doi. 10.1007/s00280-014-2476-y
- By:
- Publication type:
- Article
Results of a phase 1, randomized study evaluating the effects of food and diurnal variation on the pharmacokinetics of linifanib.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 55, doi. 10.1007/s00280-014-2475-z
- By:
- Publication type:
- Article
A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 15, doi. 10.1007/s00280-014-2467-z
- By:
- Publication type:
- Article
Protracted dosing of the lipophilic camptothecin analogue AR-67 in non-small cell lung cancer xenografts and humans.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 45, doi. 10.1007/s00280-014-2472-2
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of capecitabine in combination with radiotherapy in patients with localised inoperable pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 131, doi. 10.1007/s00280-014-2470-4
- By:
- Publication type:
- Article
Irinotecan and temozolomide brain distribution: a focus on ABCB1.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 185, doi. 10.1007/s00280-014-2490-0
- By:
- Publication type:
- Article
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors.
- Published in:
- 2014
- By:
- Publication type:
- Report
A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 37, doi. 10.1007/s00280-014-2478-9
- By:
- Publication type:
- Article
Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer.
- Published in:
- 2014
- By:
- Publication type:
- Report
Population pharmacokinetics of imatinib in Iranian patients with chronic-phase chronic myeloid leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 85, doi. 10.1007/s00280-014-2473-1
- By:
- Publication type:
- Article
Anti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 1, doi. 10.1007/s00280-014-2489-6
- By:
- Publication type:
- Article
Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 125, doi. 10.1007/s00280-014-2480-2
- By:
- Publication type:
- Article
Interferon alpha plus 13- cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 177, doi. 10.1007/s00280-014-2427-7
- By:
- Publication type:
- Article
High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with Tc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 211, doi. 10.1007/s00280-014-2477-x
- By:
- Publication type:
- Article
Selective cellular uptake and retention of SN 28049, a new DNA-binding topoisomerase II-directed antitumor agent.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 25, doi. 10.1007/s00280-014-2469-x
- By:
- Publication type:
- Article
Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 141, doi. 10.1007/s00280-014-2482-0
- By:
- Publication type:
- Article
Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 167, doi. 10.1007/s00280-014-2451-7
- By:
- Publication type:
- Article